| 标题 |
Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Neurology 作者:Merit Cudkowicz; Merit Cudkowicz; Jeremy M. Shefner; Leonard H. van den Berg; Adriano Chio; et al 出版日期:2026-09-09 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)